TVCMALL brings one-stop wholesale solution to MWC 2023
10.3.2023 15:57:00 EET | Business Wire | Press release
Recently, the 2023 Mobile World Congress (MWC) held in Barcelona turned out to be a big success. More than 88,000 attendees and 2400+ exhibitors participated in this event, including many cell phone accessories suppliers & wholesalers. As Europe's leading one-stop shop for mobile accessories and wholesale/integrated supply chain service platform, TVCMALL participated in this digital/mobile feast. TVCMALL, based in Shenzhen China, the world's electronic center, provides the esteemed customer B2B solution on mobile accessories for wholesale, sourcing, and customization. Various classic mobile cases with leather finishing, chargers with multifunctions, and Amorus portable Karaoke speaker brought by TVCMALL were highly praised by our attendees.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230307005650/en/
TVCMALL brings one-stop wholesale solution to MWC 2023 (Photo: Business Wire)
MWC is one of the world's most important telecommunications & technology shows. During the past 4 days, the aspects such as the latest trend in mobile technologies, including Intelligent equipment, 5G network, AI, and digitalization, have been introduced and shared with the world.
During the show, TVCMALL met a lot of old customers and new friends. Many of them are as follows:
- Top online mobile phone accessories retailers & distributors
- B2C platform sellers, Dropshippers
- Offline chain stores, Supermarket sellers, Telecom companies
- Gift-Customize customers (especially for government, corporate & schools and other agents)
- OEM & ODM & OBM customers
- Retail shops & Mobile phone repair shops
Many customers have cooperated with TVCMALL for over ten years since its establishment in 2008, and they have grown and developed rapidly with TVCMALL. They expressed their high recognition and gratitude to TVCMALL for providing one-stop wholesale, sourcing, customized services, and other supply chain services.
Why they choose TVCMALL as an indispensable and important long-term partner? Because TVCMALL provides complete product catalog, with more than 600,000 SKU online, and every week 6,000 new products updated. Its wholesale process, marketing support, and customer service are efficient. TVCMALL has good intention of growing together with their customers.
TVCMALL's comprehensive procurement cost is relatively low, the service consistency and stability are very strong. That’s why many customers prefer one-stop service providers like TVCMALL.
During the MWC, TVCMALL has established a bridge of contact with some excellent product suppliers and e-commerce service providers (of mobile, 3C electronic devices and accessories).
In the foreseeable future, with continuously TVCMALL brand and platform upgrading, TVCMALL will strengthen its mission, "To help entrepreneurs actualize their dreams of launching and sustaining a successful retail business", and will stick to its business operation philosophy "Together we thrive". In terms of specific strategies, TVCMALL will adhere to the following 4 directions:
- Platform Branding — Operate the TVCMALL platform as a future century-old brand
- Productization of the services — all the services of TVCMALL with the idea of Productization.
- Product Deep ploughing — Thrive to be the best.
- Localization of TVCMALL service — Go global and localization: Initiate local marketing and service team, in-depth understanding & efficient service.
TVCMALL will see you again in Barcelona 2024!
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230307005650/en/
Contact information
Shenzhen Zhenzhi Technology Co.,Ltd.
Yelly Huang
global@tvcmall.com
https://www.tvcmall.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom